Liraglutide + PYY336 combination therapy mimics effects of Roux-en-Y bypass on early NAFLD whilst lacking-behind in metabolic improvements
Both work for topical use
They can be life-saving in status epilepticus (repeated fits, one after another) and in fits caused by overdose of certain drugs (for example, tricyclic antidepressants)
Unlike over-the-counter weight loss products or supplements that may work temporarily or contain untested ingredients, GLP-1 treatments are regulated and approved by the Food and Drug Administration (FDA)
Red flags exist: Unusually low prices, no prescription requirements, overseas shipping, and lack of transparency all suggest potential quality concerns
Opinions and statements of financial market trends that are based on current market conditions constitute judgment of the author and are subject to change without notice